Enhancing sensitivity of lateral flow assay with application to SARS-CoV-2
- PMID: 33012808
- PMCID: PMC7518548
- DOI: 10.1063/5.0021842
Enhancing sensitivity of lateral flow assay with application to SARS-CoV-2
Abstract
Lateral flow assay (LFA) has long been used as a biomarker detection technique. It has advantages such as low cost, rapid readout, portability, and ease of use. However, its qualitative readout process and lack of sensitivity are limiting factors. We report a photon-counting approach to accurately quantify LFAs while enhancing sensitivity. In particular, we demonstrate that the density of SARS-CoV-2 antibodies can be quantified and measured with an enhanced sensitivity using this simple laser optical analysis.
Copyright © 2020 Author(s).
Figures




References
-
- Zhang W., Du R.-H., Li B., Zheng X.-S., Yang X.-L., Hu B., Wang Y.-Y., Xiao G.-F., Yan B., Shi Z.-L. et al., “ Molecular and serological investigation of 2019-nCoV infected patients: Implication of multiple shedding routes,” Emerging Microbes Infect. 9, 386–389 (2020).10.1080/22221751.2020.1729071 - DOI - PMC - PubMed
-
- Folegatti P. M., Ewer K. J., Aley P. K., Angus B., Becker S., Belij-Rammerstorfer S., Bellamy D., Bibi S., Bittaye M., Clutterbuck E. A. et al., “ Safety and immunogenicity of the chadox1 ncov-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1/2, single-blind, randomised controlled trial,” Lancet 396, 467 (2020).10.1016/S0140-6736(20)31604-4 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous